China’s CDE- Guidelines for Summary of Adverse Drug Reaction Data in Labeling of Antineoplastic Drugs
China’s CDE issued on March 21st, 2022 the guidelines for the listing Adverse reaction in package inserts.
China’s CDE issued on March 21st, 2022 the guidelines for the listing Adverse reaction in package inserts.
Copyright ©2023 Global Regulatory Partners